US Stock MarketDetailed Quotes
ZVRA Zevra Therapeutics
- 6.300
- 0.0000.00%
Close Aug 2 16:00 ET
- 9.030
- +2.730+43.33%
Post 20:02 ET
263.68MMarket Cap-4772P/E (TTM)
0.000High0.000Low556.13KVolume6.300Open6.300Pre Close4.85MTurnover1.54%Turnover RatioLossP/E (Static)41.85MShares7.28052wk High5.40P/B227.28MFloat Cap3.89052wk Low--Dividend TTM36.08MShs Float418.400Historical High--Div YieldTTM0.00%Amplitude2.560Historical Low8.713Avg Price1Lot Size
Zevra Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.84%3.43M | 170.26%27.46M | 553.66%13.22M | 0.73%2.9M | 551.54%8.47M | -19.90%3.18M | -64.53%10.16M | -21.69%2.02M | 46.26%2.87M | -89.15%1.3M |
| Operating revenue | 7.84%3.43M | 170.26%27.46M | 553.66%13.22M | 0.73%2.9M | 551.54%8.47M | -19.90%3.18M | -64.53%10.16M | -21.69%2.02M | 46.26%2.87M | -89.15%1.3M |
| Cost of revenue | 1,262.40%1.7M | 1,226.58%2.95M | 8,986.36%2M | 2.13%144K | 1,227.45%677K | 1,462.50%125K | -89.22%222K | -62.71%22K | 141K | -94.90%51K |
| Gross profit | -43.56%1.72M | 146.66%24.52M | 460.90%11.22M | 0.66%2.75M | 523.94%7.79M | -22.90%3.05M | -62.62%9.94M | -20.73%2M | 39.08%2.73M | -88.63%1.25M |
| Operating expense | 39.83%22.21M | 112.74%74.12M | 128.84%25.89M | 93.56%18.12M | -44.50%14.44M | 173.07%15.88M | 84.72%34.84M | 110.87%11.31M | 123.53%9.36M | 404.87%26.02M |
| Selling and administrative expenses | 37.42%9.93M | 128.18%34.31M | 207.15%14.66M | 46.40%5.82M | 96.88%7.01M | 164.34%7.23M | 72.83%15.04M | 86.70%4.77M | 104.00%3.97M | 54.36%3.56M |
| Research and development costs | 41.85%12.28M | 101.01%39.81M | 71.72%11.23M | 128.36%12.3M | -66.90%7.43M | 180.82%8.66M | 94.89%19.8M | 132.86%6.54M | 140.51%5.39M | 688.55%22.46M |
| Operating profit | -59.66%-20.49M | -99.20%-49.6M | -57.53%-14.67M | -131.87%-15.36M | 73.17%-6.65M | -590.21%-12.83M | -422.19%-24.9M | -227.69%-9.31M | -198.20%-6.63M | -524.60%-24.77M |
| Net non-operating interest income expense | -77.44%194K | 158.06%3.04M | -163.41%-546K | 1,359.57%1.37M | 310.91%1.36M | 743.14%860K | 1,124.35%1.18M | 617.50%861K | -28.24%94K | 1,420.00%330K |
| Non-operating interest income | -10.84%929K | 200.13%4.54M | -79.63%210K | 697.25%1.74M | 324.32%1.55M | 873.83%1.04M | 479.69%1.51M | 724.80%1.03M | 59.12%218K | --366K |
| Non-operating interest expense | 303.85%735K | 348.06%1.5M | 344.71%756K | 195.16%366K | 447.22%197K | 3,540.00%182K | -10.90%335K | 3,300.00%170K | 1,966.67%124K | 44.00%36K |
| Other net income (expense) | 366.86%3.6M | 116.72%515K | -99.57%64K | 205.98%124K | 140.94%131K | -1,115.32%-1.35M | 80.90%-3.08M | 28,052.83%14.92M | -135.24%-117K | -181.01%-320K |
| Gain on sale of security | 366.86%3.6M | -96.47%515K | -99.57%64K | 205.98%124K | 140.94%131K | -1,115.32%-1.35M | 37,489.74%14.58M | 28,052.83%14.92M | -135.24%-117K | 18.78%-320K |
| Special income (charges) | ---- | --0 | --0 | --0 | ---- | ---- | -9.74%-17.66M | --0 | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | 9.74%17.66M | --0 | ---- | ---- |
| Income before tax | -25.32%-16.69M | -71.79%-46.05M | -334.24%-15.15M | -108.57%-13.87M | 79.17%-5.16M | -613.06%-13.32M | -214.58%-26.81M | 342.38%6.47M | -278.00%-6.65M | -499.11%-24.76M |
| Income tax | 32.04%-70K | 0 | 0 | 636.36%177K | 89.65%-74K | -2,475.00%-103K | -197.06%-33K | 2,014.71%719K | -33K | -715K |
| Net income | -25.76%-16.62M | -72.00%-46.05M | -363.53%-15.15M | -112.29%-14.05M | 78.85%-5.08M | -609.07%-13.22M | -212.94%-26.77M | 312.73%5.75M | -276.12%-6.62M | -487.59%-24.04M |
| Net income continuous Operations | -25.76%-16.62M | -72.00%-46.05M | -363.53%-15.15M | -112.29%-14.05M | 78.85%-5.08M | -609.07%-13.22M | -212.94%-26.77M | 312.73%5.75M | -276.12%-6.62M | -487.59%-24.04M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -25.76%-16.62M | -72.00%-46.05M | -363.53%-15.15M | -112.29%-14.05M | 78.85%-5.08M | -609.07%-13.22M | -212.94%-26.77M | 312.73%5.75M | -276.12%-6.62M | -487.59%-24.04M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -25.76%-16.62M | -72.00%-46.05M | -363.53%-15.15M | -112.29%-14.05M | 78.85%-5.08M | -609.07%-13.22M | 57.44%-26.77M | 312.73%5.75M | -276.12%-6.62M | -124.80%-24.04M |
| Basic earnings per share | -5.26%-0.4 | -66.67%-1.3 | -350.00%-0.4 | -110.53%-0.4 | 78.57%-0.15 | -660.00%-0.38 | 63.03%-0.78 | 220.00%0.16 | -280.00%-0.19 | -75.00%-0.7 |
| Diluted earnings per share | -5.26%-0.4 | -66.67%-1.3 | -350.00%-0.4 | -110.53%-0.4 | 78.57%-0.15 | -660.00%-0.38 | 63.03%-0.78 | 220.00%0.16 | -280.00%-0.19 | -75.00%-0.7 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg